🇺🇸 FDA
Patent

US 7256279

Protein having ribonucleotide reductase activity and DNA thereof

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 7256279 (Protein having ribonucleotide reductase activity and DNA thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 14 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K38/00